(secondQuint)Post Study Continuation of C7 for G1D.

 Only patients who completed the initial pilot study were eligible.

 The study is ongoing with these patients only.

.

 Post Study Continuation of C7 for G1D@highlight

This protocol provides ongoing access to triheptanoin for patients who did complete an initial pilot protocol, and provides the opportunity to collect long-term safety data from patients treated with triheptanoin.

